| NICE drops recommended use of cancer drug nivolumab Related items from OnMedica NHS cancer patients still denied treatments available in other countries Brexit could bar child patients from cancer trials 75% of reappraised CDF drugs approved for NHS Study shows huge global variation in cancer drug costs Controversial new drug approval system unveiled |
Tuesday, 11 April 2017
Cancer experts condemn cancer drug decision
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment